放射治疗
医学
机制(生物学)
癌症研究
放射性损伤
病理
癌
放射科
肿瘤科
外科
内科学
辐照
辐射
核医学
癌症
化学
作者
邹晓防,Zheng Zhang,Xiaowei Zhang,Yixuan Gao,Rui Xiao
标识
DOI:10.1016/j.jrras.2026.102597
摘要
Background Radiotherapy has shown clinical effectiveness in scar carcinoma, but the underlying mechanisms—particularly its effects on the tumor immune microenvironment—remain unclear. This research intends to support a new hypothesis: that radiotherapy alters the tumor microenvironment in scar carcinoma by stimulating the “p53-Smad7-TGF-β" signaling pathway, which subsequently inhibits critical pathogenic mechanisms and alleviates immunosuppression. This exploratory translational study combined public transcriptomic data with experimental validation to investigate radiotherapy response in burn scar carcinoma. Methods The analysis combined public single-cell and bulk transcriptomic datasets with in vitro functional validation experiments. Additionally, two laboratory cell experiments were designed for functional validation. Bioinformatics analyses employed Seurat, CellChat, Monocle2, limma, and various machine learning techniques. The cell experiments utilized a human burn scar carcinoma cell line, with dose-response validation groups and mechanism recovery validation groups established. Parameters such as cell proliferation, key gene expression, mitochondrial membrane potential, and TGF-β secretion were assessed using the CCK-8 assay, q-PCR, TMRE detection, and ELISA techniques. Results Augur analysis unequivocally identified myeloid-derived suppressor cells (MDSCs) as the primary cell type exhibiting the most significant functional dysregulation following radiotherapy. Consistent results from multi-omics data indicate that the p53-Smad7 signaling pathway is activated post-radiotherapy, while the TGF-β/Smad pathway is suppressed. In vitro experiments demonstrated that post-radiotherapy, p53 and Smad7 mRNA expression increases dose-dependently, accompanied by reduced cellular proliferative activity; downregulation of p53 expression partially counteracts the radiation-induced elevation of Smad7 levels and suppression of TGF-β secretion, whereas introduction of a Smad7 activator restores these effects. Conclusion This study provides multi-omics and experimental evidence supporting the involvement of the p53-Smad7-TGF- axis in radiotherapy-induced immune remodeling in burn scar carcinoma. The activation of this axis constitutes the fundamental mechanism underlying the dual effects of radiotherapy—namely, direct suppression of tumor cell activity and enhancement of antitumor immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI